Global Viral Vector Production Market Reprot 2023: Clinical
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Vector Engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The
VANCOUVER, B.C., August 16, 2023 - Tectonic Metals Inc. TECT: TSX-V; TETOF: OTCQB; T15B: FSE) , a mineral exploration company employing a rigorous up-front approach to addressing project risk,... -Today at 07:11 am- MarketScreener
Tectonic Metals Attracts Leading Exploration and Mining Experts to ...
Phase 3 LUMEOS clinical trial of botaretigene sparoparvovec (bota-vec, formerly AAV-RPGR) for the treatment of X-linked retinitis pigmentosa (XLRP) enrollment target has now been surpassedAnnounced positive clinical data from the completed AQUAx Phase 1 study of AAV2-hAQP1 for the treatment of grade 2/3 radiation-induced xerostomia (RIX), showing bilaterally treated participants reaching normal levels of whole saliva flow rate by 2 months post-treatment and persisting through the final Month 12
14.03.2023 - - Announced positive clinical data from AQUAx AAV-hAQP1 Phase 1 trial for treatment of Grade 2/3 Radiation-Induced Xerostomia in December 2022 - Announced positive top-line data from the MGT009 Phase 1/2 clinical study demonstrating safety and ...